Junshi Biosciences Announces Acceptance by NMPA of its IND Application for JS006

    NEXT STORY
    Amarin Files Patent Infringement Lawsuit Against Hikma
    PREV STORY
    Skylight Health Reports Q3 Results Achieving Consecutive Quarter and YTD Positive Adjusted EBITDA
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Oncology Pharma Announces the Appointment Of New Chief Financial Officer

    author_avatar
    NASDAQ Market News

    Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data at the Society for Immunotherapy of Cancer Conference 2016

    Presentation provides immunologic and booster data on GALE-301/GALE-302 SAN RAMON, Calif., Nov. 14, 2016 ...

    author_avatar
    NASDAQ Market News

    Cue Biopharma Announces Changes to its Board of Directors

    author_avatar
    NASDAQ Market News